1. Emmis Acquisition Corp. announces IPO of 10 million units at $10 each. 2. Units will trade on Nasdaq under ticker 'EMISU' starting September 25, 2025. 3. Each unit includes one share and a right for one-tenth of a share. 4. Closing of IPO is expected on September 26, 2025, subject to conditions. 5. The company aims to pursue diverse acquisition opportunities in various sectors.

1. IBG announces a non-binding merger with BlockFuel Energy. 2. Merger values IBG post-transaction between $22M and $34.3M. 3. Daniel Lanskey to become new CEO of IBG post-merger. 4. Shareholders will own 10% of the new combined entity. 5. Transaction requires further negotiations and regulatory approvals.

1. IBG announced a 5-for-1 reverse stock split effective September 26, 2025. 2. This split reduces shares from 11.6M to 2.3M, aiming to increase stock price. 3. IBG received a delisting letter from Nasdaq but has requested a hearing. 4. The company continues trading under the symbol IBG on Nasdaq after the split. 5. They boast a growing beverage portfolio with successful premium brands.

1. Sunrise EPOW shows profitability with $0.57 million net profit for July/August. 2. July sales reached $5.2 million; August sales at $4.7 million. 3. In-house graphitization is reducing costs, leading to increased profitability. 4. Construction of 20,000-ton graphite production line commenced, enhancing capacity. 5. Renewable energy sources contribute to low-cost manufacturing for EPOW.

1. Youxin Technology acquires 51% of Celnet Technology for $736,461. 2. Acquisition expands Youxin's SaaS capabilities and strengthens AI-driven CRM services. 3. Celnet is a leading Salesforce partner in China, enhancing Youxin's strategic position. 4. The deal aims for immediate synergies and long-term revenue growth for Youxin. 5. CEO emphasizes the acquisition will create sustainable value for shareholders.

1. Crinetics received FDA approval for PALSONIFY as first-line acromegaly treatment. 2. PALSONIFY offers rapid and durable biochemical control for acromegaly patients. 3. Launch signifies a milestone for Crinetics as a key player in endocrinology. 4. Investor call scheduled today to discuss PALSONIFY's market strategy and impact. 5. Crinetics establishes supportive program, CrinetiCARE, to assist patients using PALSONIFY.

1. LPTH reported a 41.4% revenue increase in Q4 FY2025. 2. Secured $40.3 million in IR camera orders, boosting future revenue. 3. Operating expenses rose by 52%, mainly due to integration costs. 4. Significant focus on Germanium-free optics to mitigate supply chain risks. 5. Net loss increased to $7.1 million, reflecting higher operational costs.

1. Novacap agrees to acquire IAS for $10.30 per share in cash. 2. Transaction values IAS at approximately $1.9 billion. 3. Acquisition offers IAS resources to enhance AI-first technology. 4. Shareholders approved the transaction, no further consent required. 5. IAS to operate as a private company post-acquisition.

1. Marvell announces a $5 billion stock repurchase program. 2. The company completed $300 million in repurchases in the current quarter. 3. Marvell entered a $1 billion accelerated share repurchase agreement. 4. CEO emphasizes commitment to revenue growth and AI infrastructure investment. 5. Fireside chat with CEO scheduled for September 24, 2025.

1. Crane NXT expects high-single-digit growth in 2026 for U.S. Currency business. 2. Projected demand for banknotes ranges from 3.8 billion to 5.1 billion. 3. Higher denomination banknotes demand is expected to increase by 90%. 4. CEO expresses confidence in Crane Currency's trajectory and international markets. 5. Acquisition of Antares Vision supports strategy for advanced technology solutions.